Philips Handheld Blood Test Shows Further Promise in Clinical Setting

Home logo_363x90 Healthcare Philips Handheld Blood Test Shows Further Promise in Clinical Setting

Philips Handheld Blood Test Shows Further Promise in Clinical Setting

Eindhoven, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) has completed its first field study for its Minicare handheld cardiac Troponin-I (cTn-I) blood test, demonstrating the platform’s potential to produce lab-equivalent results with finger prick samples within minutes.

/ Healthcare

Share the Post

About the Author

Philips Respironics

Philips Respironics, a global leader in the sleep and respiratory markets, is passionate about providing solutions that lead to healthier patients, healthier practices, and healthier businesses. For us, innovation is driven by gaining insight into the needs of the people who use our products in the areas of sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery.

Related Posts

Read More
The Pain of Sleep Problems By Gina Roberts-Grey Tossing and…
Read More
What Does a COPD Flare-up Look Like? By Jennifer Nelson Chronic…
The Institute of Cancer Research joins the Elekta and Philips research consortium to develop MRI-guided therapy system for cancer treatment
Read More
Which Came First, Insomnia or Sleep Apnea? By Jennifer…
Read More
Can You Really ‘Sleep What You Eat?’ By G R You…
Read More
What Smokers Can Do to Detect COPD Early By Reyna…
Read More
Think About It: Sleep Can Help Boost Memory By Jennifer…
Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions